首页> 外文期刊>Best practice & research:Clinical obstetrics & gynaecology >Pregnancies in liver and kidney transplant recipients: a review of the current literature and recommendation
【24h】

Pregnancies in liver and kidney transplant recipients: a review of the current literature and recommendation

机译:肝肾移植受者的妊娠:当前文献和建议的回顾

获取原文
获取原文并翻译 | 示例
           

摘要

In this article, we focus on the biggest groups of organ transplant recipients, patients with a kidney or liver graft. Among these patients, about one sixth included women of childbearing potential. Therefore, the wish of getting pregnant is frequent in these peculiar patients, and careful planning and management of the pregnancies requires the expertise of obstetricians, midwives and transplant experts. Altogether, the outcome of the pregnancies in these women is acceptable. About 75% off all pregnancies ended successfully with live births, and this is comparable if not superior to pregnancies in healthy women. This success might be caused not only by the special and intensive care provided to these high-risk pregnancies by the transplant centres but also by the low rate of unplanned pregnancies. The risk of rejections and organ loss after delivery is about 10%, and it is slightly enhanced in liver transplant recipients (LTRs) in comparison to kidney graft recipients (KTRs) but the number of organ losses in direct association with a pregnancy is rare. However, there is not only a higher frequency of pregnancy-associated disorders such as pre-eclampsia and preterm delivery but also an acceleration of hypertension, new-onset diabetes mellitus and newly arising infections also favoured by the maintained immunosuppressive therapy. This implies a specialized 'control system' for these pregnant women that comprises ultrasound and Doppler investigation for risk assessment, infection screening, suitable therapy and the choice of non-teratogenic immunosuppressives. Antihypertensive treatment must be well balanced and adjusted to the possible growth-retarding effect on the foetus as well as on the co-morbidity of the mother. Finally, supplementation of vitamin D and iron is much more important in these transplanted women than in healthy pregnant women as vitamin D deficiency and anaemia are discussed to have an impact on pre-eclampsia and preterm delivery. These claims are widely discussed. Furthermore, the current literature is systematically reviewed by Scopus analysis. (C) 2014 Elsevier Ltd. All rights reserved.
机译:在本文中,我们重点介绍器官移植受者的最大群体,即接受肾脏或肝脏移植的患者。在这些患者中,约有六分之一包括有生育能力的妇女。因此,在这些特殊患者中,怀孕的愿望很常见,并且精心计划和管理怀孕需要妇产科医生,助产士和移植专家的专业知识。总之,这些妇女的怀孕结果是可以接受的。所有妊娠中约有75%成功以活产结束,这与健康女性的妊娠水平相当甚至更高。成功的原因可能不仅是移植中心为这些高危妊娠提供了特殊而深入的照料,而且还归因于计划外妊娠的低发生率。分娩后排斥和器官丢失的风险约为10%,与肾移植受者(KTR)相比,肝移植受者(LTR)的风险稍有增加,但是与妊娠直接相关的器官损失数量很少。但是,不仅与子痫前期和早产等妊娠相关的疾病发生率更高,而且持续的免疫抑制疗法也有利于高血压,新发糖尿病和新发感染的加速。这意味着针对这些孕妇的专门“控制系统”,包括超声和多普勒检查,以进行风险评估,感染筛查,合适的治疗方法以及非致畸性免疫抑制剂的选择。降压治疗必须得到很好的平衡,并调整到可能对胎儿以及母亲的合并症造成的延缓生长的作用。最后,补充维生素D和铁在这些移植妇女中比在健康孕妇中更为重要,因为讨论了维生素D缺乏和贫血对先兆子痫和早产有影响。这些主张被广泛讨论。此外,当前的文献通过Scopus分析进行了系统地综述。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号